Advantages of chemotherapy and hypomethylating agents in myelodysplastic syndrome
Maria T. Voso et al.
Overview of the CLL13 trial: replacing chemotherapy with venetoclax-containing regimens
Julia von Tresckow
Use of novel algorithms based on pattern recognition to identify patients in need of CLL treatment